Potential Therapeutic Actions of Flavonoids Present in Propolis That Modulate Vascular Endothelial Growth Factor Signaling to Regulate Angiogenesis
Phytotherapy Research · 2025
DOI: 10.1002/ptr.70029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Yipeng Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Drug Development Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australi…. Hauptthemen laut MEDLINE: Propolis, Flavonoids, Signal Transduction, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine and Health, University of Sydney (SOMS honors scholarship).
Abstract (Originalsprache)
Propolis is a plant‐derived substance collected by honeybees that has a range of potential therapeutic applications. Propolis consists of resins, waxes, and fatty acids, as well as essential oils and other organic compounds. The pharmacologically active components of propolis include phenols and flavonoids, among others. Flavonoids that are found in propolis include chrysin, quercetin, galangin, kaempferol, and apigenin. Angiogenesis is the growth of new blood vessels from endothelial cell precursors. Angiogenesis is important in normal physiology and development. Pathological angiogenesis is widely implicated in human diseases, such as retinal diseases, cancers, and inflammatory diseases; currently, many of these conditions lack effective treatments. The process of angiogenesis is modulated by pro‐angiogenic factors, in particular, Vascular Endothelial Growth Factor (VEGF). Flavonoids, including several that are present in propolis, have been found to inhibit angiogenesis by attenuating VEGF signaling. Although promising, such findings are primarily based on preclinical studies, and few clinical studies have evaluated the efficacy and toxicity of flavonoids in vivo. This review outlines the therapeutic potential of essential flavonoids from propolis that may have value as anti‐angiogenic agents by modulating VEGF signaling. Overall, the findings suggest that flavonoids that are present in propolis are potential agents for the treatment of human diseases in which pathological angiogenesis is activated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Drug Development Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Macular Research Group, Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Fanfan Zhou
Förderung
- Faculty of Medicine and Health, University of Sydney (SOMS honors scholarship)
Zitieren
APA
Lin, Y., Wang, J. Z., Niu, Y., Zhu, L., Duke, R. K., Duke, C. C., Murray, M., & Zhou, F. (2025). Potential Therapeutic Actions of Flavonoids Present in Propolis That Modulate Vascular Endothelial Growth Factor Signaling to Regulate Angiogenesis. Phytotherapy Research. https://doi.org/10.1002/ptr.70029
Vancouver
Lin Y, Wang JZ, Niu Y, Zhu L, Duke RK, Duke CC, et al. Potential Therapeutic Actions of Flavonoids Present in Propolis That Modulate Vascular Endothelial Growth Factor Signaling to Regulate Angiogenesis. Phytotherapy Research. 2025. doi:10.1002/ptr.70029
BibTeX
@article{Lin2025,
author = {Lin, Yipeng and Wang, Janney Z and Niu, Yihe and Zhu, Ling and Duke, Rujee K and Duke, Colin C and Murray, Michael and Zhou, Fanfan},
title = {Potential Therapeutic Actions of Flavonoids Present in Propolis That Modulate Vascular Endothelial Growth Factor Signaling to Regulate Angiogenesis},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.70029}
}
EUVIMED